Arcutis Biotherapeutics reported revenue of $129.86M and net income of $15.01M for the quarter ended Jun 2026, up 59.3% year over year. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||
| Revenue | 0.72M | 2.96M | 2.78M | 5.19M | 38.11M | 13.53M | 49.57M | 30.86M | 44.76M | 71.36M | 65.85M | 81.50M | 99.22M | 129.50M | 105.40M | 129.86M | ||||||||||||||
| Cost of RevenueCost of Rev | 0.27M | 0.48M | 0.78M | 0.78M | 1.18M | 2.25M | 3.26M | 3.46M | 5.50M | 6.91M | 8.83M | 7.49M | 8.69M | 11.69M | 9.78M | 10.94M | ||||||||||||||
| Gross Profit | 0.46M | 2.48M | 2.00M | 4.41M | 36.93M | 11.28M | 46.31M | 27.39M | 39.25M | 64.45M | 57.02M | 74.01M | 90.53M | 117.81M | 95.61M | 118.92M | ||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 40.60M | 52.56M | 40.62M | 38.20M | 69.73M | 33.88M | 35.34M | 25.22M | 26.24M | 23.77M | 23.14M | 19.30M | 19.50M | 14.48M | 17.54M | 19.45M | 19.60M | 20.45M | 30.63M | 20.36M | ||||||||||
| Selling, General & AdministrativeSG&A | 16.47M | 18.73M | 22.01M | 27.62M | 35.47M | 37.02M | 42.92M | 45.96M | 47.59M | 48.67M | 54.79M | 58.17M | 58.82M | 57.61M | 64.00M | 69.17M | 62.40M | 78.98M | 74.08M | 82.14M | ||||||||||
| Other Operating ExpensesOther Opex | 0.27M | 0.48M | 0.78M | 0.78M | 1.18M | 2.25M | 3.26M | 3.46M | 5.50M | 6.91M | 8.83M | 7.49M | 8.69M | 11.69M | 9.78M | 10.94M | ||||||||||||||
| Operating ExpensesOpex | 57.08M | 71.29M | 62.63M | 65.83M | 105.47M | 71.39M | 79.05M | 71.95M | 75.01M | 74.69M | 81.19M | 80.94M | 83.82M | 78.99M | 90.38M | 96.11M | 90.69M | 111.12M | 114.49M | 113.43M | ||||||||||
| Operating IncomeOp. Inc | -57.08M | -71.29M | -62.63M | -65.83M | -104.75M | -68.42M | -76.27M | -66.76M | -36.90M | -61.17M | -31.62M | -50.08M | -39.07M | -7.63M | -24.53M | -14.61M | 8.53M | 18.39M | -9.09M | 16.43M | ||||||||||
| EBIT | -57.08M | -71.29M | -62.63M | -65.83M | -104.75M | -68.42M | -76.27M | -66.76M | -36.90M | -61.17M | -31.62M | -50.08M | -39.07M | -7.63M | -24.53M | -14.61M | 8.53M | 18.39M | -9.09M | 16.43M | ||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.84M | 2.00M | 4.90M | 6.92M | 7.04M | 7.35M | 7.56M | 7.76M | 7.48M | 7.48M | 6.65M | 5.55M | 2.98M | 3.03M | 3.07M | 3.00M | 4.37M | 3.41M | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | -0.24M | -0.77M | -0.23M | -0.34M | 0.51M | 0.72M | 0.13M | 0.17M | 11.50M | -0.12M | -0.13M | 0.77M | 15.60M | -0.14M | 2.08M | 0.07M | 9.06M | -0.35M | 2.28M | ||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.10M | -0.04M | 0.14M | 0.42M | 1.94M | 3.32M | 3.21M | 3.12M | 2.72M | -9.85M | 4.04M | 5.23M | 4.18M | -13.41M | 0.19M | 0.02M | 2.04M | -6.42M | -0.02M | -0.16M | ||||||||||
| Non Operating IncomeNon Op. Inc. | 0.10M | -0.04M | -1.70M | -1.58M | -2.96M | -3.60M | -3.83M | -4.23M | -0.93M | -1.28M | ||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||
| EBT | -57.06M | -71.52M | -65.23M | -68.06M | -107.71M | -72.02M | -80.10M | -70.99M | -41.74M | -66.26M | -35.06M | -52.33M | -41.54M | -10.46M | -24.78M | -15.54M | 7.49M | 17.86M | -11.20M | 15.14M | ||||||||||
| Tax ProvisionsTaxes | 3.02M | 0.03M | 0.32M | 0.32M | 0.28M | 0.34M | 0.08M | 0.50M | 0.09M | 0.14M | ||||||||||||||||||||
| Profit After TaxPAT | -56.98M | -71.56M | -64.32M | -67.41M | -108.05M | -71.51M | -80.10M | -70.99M | -44.77M | -66.28M | -35.38M | -52.33M | -41.54M | -10.80M | -25.06M | -15.89M | 7.41M | 17.41M | -11.29M | 15.01M | ||||||||||
| Income from Continuing OperationsIncome (Continuing) | -57.06M | -71.52M | -65.23M | -68.06M | -107.71M | -72.02M | -80.10M | -70.99M | -44.77M | -66.28M | -35.38M | -52.33M | -41.54M | -10.79M | -25.06M | -15.89M | 7.41M | 17.37M | -11.29M | 15.01M | ||||||||||
| Consolidated Net IncomeConsol Net Inc. | -57.06M | -71.52M | -65.23M | -68.06M | -107.71M | -72.02M | -80.10M | -70.99M | -44.77M | -66.28M | -35.38M | -52.33M | -41.54M | -10.79M | -25.06M | -15.89M | 7.41M | 17.37M | -11.29M | 15.01M | ||||||||||
| Income towards Parent CompanyParent Net Inc | -57.06M | -71.52M | -65.23M | -68.06M | -107.71M | -72.02M | -80.10M | -70.99M | -44.77M | -66.28M | -35.38M | -52.33M | -41.54M | -10.79M | -25.06M | -15.89M | 7.41M | 17.37M | -11.29M | 15.01M | ||||||||||
| Net Income towards Common StockholdersNet Income | -57.06M | -71.52M | -65.23M | -68.06M | -107.71M | -72.02M | -80.10M | -70.99M | -44.77M | -66.28M | -35.38M | -52.33M | -41.54M | -10.79M | -25.06M | -15.89M | 7.41M | 17.37M | -11.29M | 15.01M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| EPS (Basic) | -1.14 | -1.45 | -1.29 | -1.32 | -1.89 | -1.31 | -1.31 | -1.16 | -0.73 | -0.96 | -0.32 | -0.42 | -0.33 | -0.09 | -0.20 | -0.13 | 0.06 | 0.14 | -0.09 | 0.11 | ||||||||||
| EPS (Diluted) | -1.14 | -1.45 | -1.29 | -1.32 | -1.89 | -1.31 | -1.31 | -1.16 | -0.73 | -0.96 | -0.32 | -0.42 | -0.33 | -0.09 | -0.20 | -0.13 | 0.06 | 0.14 | -0.09 | 0.11 | ||||||||||
| Shares Outstanding | 50.10M | 49.41M | 50.51M | 51.42M | 57.09M | 55.03M | 61.17M | 61.43M | 61.73M | 69.31M | 111.05M | 123.48M | 124.30M | 120.96M | 126.04M | 127.00M | 127.62M | 127.23M | 129.37M | 130.52M | ||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 50.10M | 49.41M | 50.51M | 51.42M | 57.09M | 55.03M | 61.17M | 61.43M | 61.73M | 69.31M | 111.05M | 123.48M | 124.30M | 120.96M | 126.04M | 127.00M | 132.88M | 127.23M | 129.37M | 135.90M | ||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 50.13M | 50.26M | 51.36M | 51.53M | 60.91M | 61.04M | 61.36M | 61.63M | 61.86M | 69.31M | 115.51M | 116.48M | 117.00M | 117.85M | 119.14M | 119.80M | 120.29M | 123.33M | 125.04M | 125.59M | ||||||||||
| EBITDA | -57.08M | -71.29M | -62.63M | -65.83M | -104.75M | -68.42M | -76.27M | -66.76M | -36.90M | -61.17M | -31.62M | -50.08M | -39.07M | -7.63M | -24.53M | -14.61M | 8.53M | 18.39M | -9.09M | 16.43M | ||||||||||
| Interest ExpensesInt Expense | 1.84M | 2.00M | 4.90M | 6.92M | 7.04M | 7.35M | 7.56M | 7.76M | 7.48M | 7.48M | 6.65M | 5.55M | 2.98M | 3.03M | 3.07M | 3.00M | 4.37M | 3.41M | ||||||||||||
| Tax Rate | -7.24% | -0.04% | -0.92% | -3.09% | -1.13% | -2.20% | 1.07% | 2.79% | -0.83% | 0.90% |